Prolactin as a possible predictive factor in metastatic non-small cell lung cancers (NSCLC) patients in treatment with Nivolumab (NIVO)

被引:0
|
作者
Caponnetto, S. [1 ]
Mancini, M. L. [1 ]
Scagnoli, S. [1 ]
Barchiesi, G. [1 ]
Mosillo, C. [1 ]
Iannantuono, G. M. [1 ]
Verkhovskaia, S. [1 ]
Magri, V. [1 ]
Piesco, G. [1 ]
Pomati, G. [1 ]
Pellegrino, D. [1 ]
Urbano, F. [1 ]
Zancla, S. [1 ]
Manai, C. [1 ]
Cortesi, E. [1 ]
机构
[1] Sapienza Univ Roma, Policlin Umberto 1, Oncol Med B, Rome, Italy
关键词
D O I
10.1093/annonc/mdw332.36
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A36
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Radiotherapy for non-metastatic non-small cell lung cancers
    Lartigau, Eric Felix
    Le Tinier, Florence
    Gaye, Elisabeth
    Dansin, Eric
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2025, 209 (02): : 275 - 279
  • [32] Treatment of non-small cell lung cancer (NSCLC)
    Zarogoulidis, Konstantinos
    Zarogoulidis, Paul
    Darwiche, Kaid
    Boutsikou, Efimia
    Machairiotis, Nikolaos
    Tsakiridis, Kosmas
    Katsikogiannis, Nikolaos
    Kougioumtzi, Ioanna
    Karapantzos, Ilias
    Huang, Haidong
    Spyratos, Dionysios
    JOURNAL OF THORACIC DISEASE, 2013, 5 : S389 - S396
  • [33] First-line monotherapy with nivolumab (NIVO) in advanced non-small cell lung cancer (NSCLC): Safety, efficacy, and biomarker analyses
    Gettinger, S. N.
    Hellmann, M. D.
    Shepherd, F. A.
    Antonia, S. J.
    Brahmer, J.
    Chow, L. Q.
    Goldman, J.
    Juergens, R.
    Borghaei, H.
    Ready, N. E.
    Gerber, D. E.
    Nathan, F.
    Shen, Y.
    Harbison, C. T.
    Rizvi, N.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S632 - S632
  • [34] Phase II study of danusertib (D) in advanced/metastatic non-small cell lung cancers (NSCLC).
    Gauler, Thomas Christoph
    Besse, Benjamin
    Novello, Silvia
    Smit, Egbert F.
    Plummer, Elizabeth R.
    Delord, Jean-Pierre
    Nicodemo, Maurizio
    Santoro, Armando
    Barone, Carlo
    Marchetti, Paolo
    Conte, Pier Franco
    De Jonge, Maja J.
    Awada, Ahmad
    Mariani, Mariangela
    Jannuzzo, Maria Gabriella
    Petroccione, Anna
    Ceruti, Roberta
    Davite, Cristina
    Eberhardt, Wilfried Ernst Erich
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [35] The predictive values of carcinoembryonic antigen (CEA) in patients with metastatic non-small cell lung cancer (NSCLC) treated with gefitinib
    Bharwani, L. D.
    Lopes, G., Jr.
    Lim, E. H.
    Hsieh, W.
    Chang, A. Y.
    Shen, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [36] Radiogenomics in 332 metastatic non-small cell lung cancer (NSCLC) patients.
    Remon, Jordi
    Faivre, Laura
    Facchinetti, Francesco
    Bluthgen, Maria Virginia
    Pignon, Jean-Pierre
    Planchard, David
    Lacroix, Ludovic
    Besse, Benjamin
    Soria, Jean-Charles
    Caramella, Caroline
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [37] Sitravatinib plus tislelizumab in patients with metastatic non-small cell lung cancer (NSCLC)
    Zhou, Q.
    Yu, X.
    Gao, B.
    Ma, Z.
    Chu, Q.
    Huang, D.
    Zhao, J.
    Day, D.
    Body, A. L.
    Pan, H.
    Cui, J.
    Li, H.
    Sun, J.
    Zhang, J.
    Fei, C.
    Wu, Y-L.
    ANNALS OF ONCOLOGY, 2022, 33 : S1 - S2
  • [38] Sitravatinib plus tislelizumab in patients with metastatic non-small cell lung cancer (NSCLC)
    Zhou, Q.
    Yu, X.
    Gao, B.
    Ma, Z.
    Chu, Q.
    Huang, D.
    Zhao, J.
    Day, D.
    Body, A. L.
    Pan, H.
    Cui, J.
    Chen, C.
    Xiang, X.
    Fei, C.
    Yang, L.
    Wu, Y-L.
    ANNALS OF ONCOLOGY, 2021, 32 : S996 - S997
  • [39] Evaluating inflammatory markers as predictive tools for advanced non-small cell lung cancer receiving nivolumab Predictive markers for nivolumab response in advanced NSCLC
    Karaboyun, Kubilay
    ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2023, 14 : 361 - 365
  • [40] Nivolumab in routine practice for older patients with advanced or metastatic non-small cell lung cancer
    Sabatier, Renaud
    Nicolas, Emanuel
    Paciencia, Maria
    Jonville-Bera, Annie-Pierre
    Madroszyk, Anne
    Cecile, Maud
    Braticevic, Cecile
    Duran, Segolene
    Tassy, Louis
    Rouby, Franck
    Micallef, Joelle
    Rousseau, Frederique
    JOURNAL OF GERIATRIC ONCOLOGY, 2018, 9 (05) : 494 - 500